Patient safety
Opioid counseling: plan for overdose before it happens
Naloxone counseling is not reserved for someone who has already overdosed. FDA recommends discussing its availability with all patients when prescribing opioid pain medicines. A useful conversation also identifies who will recognize an emergency and what they will do next.
Sources checked October 6, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Start with everyone, then assess risk
FDA recommends discussing naloxone with all patients prescribed opioid pain relievers. It identifies higher-risk situations including benzodiazepines or other CNS depressants, prior overdose and opioid use disorder.
Risk assessment is not a judgment about character. Ask about actual medicines, alcohol and household circumstances in neutral language. Do not infer safety simply because the opioid prescription is legal or short term.
Include the people nearby
FDA also recommends considering naloxone when household members, including children, or close contacts are at risk of accidental ingestion or overdose. A caregiver may be the person who needs to use the product.
Check access and training rather than only documenting that a leaflet was supplied. The patient and household need the specific product's instructions, where it will be kept, and a plan for getting emergency help.
Recognize the emergency
FDA describes slowed, shallow or difficult breathing, severe sleepiness, and inability to respond or wake as possible signs. If overdose is known or suspected, naloxone should be given if available and emergency help sought immediately.
Naloxone is temporary treatment and repeat doses may be required. Do not teach that an initial response proves the emergency is over. Follow the product instructions and emergency dispatcher guidance.
Separate rescue from routine prescribing
Having naloxone does not make opioid and sedative combinations harmless or permit unsupervised dose escalation. The medication review and overdose-response plan address different parts of safety.
This page does not choose a naloxone formulation, replace hands-on training or set an individual opioid regimen. It tests whether counseling includes a realistic emergency plan.
A worked case
A patient starting an opioid pain medicine also uses a benzodiazepine. They say their spouse can find the naloxone but believes they should call for help only if the first dose fails.
- Identify the CNS-depressant combination as an increased-risk situation in FDA guidance.
- Check the actual naloxone product and make sure the spouse knows its instructions.
- Correct the emergency plan: call 911 or get emergency help immediately for suspected overdose, including when naloxone is given.
Answer: Provide product-specific training and correct the delayed-emergency-help plan.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Should naloxone availability be discussed only after a prior overdose?
No. FDA recommends discussion with all patients when prescribing opioid pain medicines.
2. Does waking after naloxone eliminate the need for emergency help?
No. Its effect is temporary, repeat doses may be needed, and emergency help is still necessary.
3. Can household accidental-ingestion risk matter?
Yes. FDA includes at-risk household members and close contacts when considering naloxone.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.